Literature DB >> 22652999

Advances in foamy virus vector technology and disease correction could speed the path to clinical application.

Els Verhoeyen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22652999      PMCID： PMC3369289          DOI： 10.1038/mt.2012.97

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  25 in total

1.  The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV.

Authors:  Nicolas Manel; Felix J Kim; Sandrina Kinet; Naomi Taylor; Marc Sitbon; Jean-Luc Battini
Journal:  Cell       Date:  2003-11-14       Impact factor: 41.582

2.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

3.  A small-molecule-controlled system for efficient pseudotyping of prototype foamy virus vectors.

Authors:  Yu-Ping Ho; Viktor Schnabel; Anka Swiersy; Kristin Stirnnagel; Dirk Lindemann
Journal:  Mol Ther       Date:  2012-04-03       Impact factor: 11.454

4.  Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells.

Authors:  Md Nasimuzzaman; Derek A Persons
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

5.  Foamy-virus-mediated gene transfer to canine repopulating cells.

Authors:  Hans-Peter Kiem; James Allen; Grant Trobridge; Erik Olson; Kirsten Keyser; Laura Peterson; David W Russell
Journal:  Blood       Date:  2006-09-12       Impact factor: 22.113

6.  Foamy virus capsids require the cognate envelope protein for particle export.

Authors:  T Pietschmann; M Heinkelein; M Heldmann; H Zentgraf; A Rethwilm; D Lindemann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Properties of human foamy virus relevant to its development as a vector for gene therapy.

Authors:  Claire L Hill; Paul D Bieniasz; Myra O McClure
Journal:  J Gen Virol       Date:  1999-08       Impact factor: 3.891

8.  Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.

Authors:  Cordula Leurs; Michael Jansen; Karen E Pollok; Martin Heinkelein; Manfred Schmidt; Manuela Wissler; Dirk Lindemann; Christof Von Kalle; Axel Rethwilm; David A Williams; Helmut Hanenberg
Journal:  Hum Gene Ther       Date:  2003-04-10       Impact factor: 5.695

9.  Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.

Authors:  Peiman Hematti; Bum-Kee Hong; Cole Ferguson; Rima Adler; Hideki Hanawa; Stephanie Sellers; Ingeborg E Holt; Craig E Eckfeldt; Yugal Sharma; Manfred Schmidt; Christof von Kalle; Derek A Persons; Eric M Billings; Catherine M Verfaillie; Arthur W Nienhuis; Tyra G Wolfsberg; Cynthia E Dunbar; Boris Calmels
Journal:  PLoS Biol       Date:  2004-11-23       Impact factor: 8.029

10.  Centrosomal latency of incoming foamy viruses in resting cells.

Authors:  Jacqueline Lehmann-Che; Noémie Renault; Marie Lou Giron; Philippe Roingeard; Emmanuel Clave; Joelle Tobaly-Tapiero; Patricia Bittoun; Antoine Toubert; Hugues de Thé; Ali Saïb
Journal:  PLoS Pathog       Date:  2007-05-25       Impact factor: 6.823
View more
  3 in total

1.  Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.

Authors:  Martin V Hamann; Nicole Stanke; Erik Müllers; Kristin Stirnnagel; Sylvia Hütter; Benedetta Artegiani; Sara Bragado Alonso; Federico Calegari; Dirk Lindemann
Journal:  Mol Ther       Date:  2014-05-12       Impact factor: 11.454

Review 2.  CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.

Authors:  Ezgi Elmas; Noushin Saljoughian; Marcelo de Souza Fernandes Pereira; Brian P Tullius; Kinnari Sorathia; Robin J Nakkula; Dean A Lee; Meisam Naeimi Kararoudi
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

Review 3.  Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy.

Authors:  Alejandra Gutierrez-Guerrero; François-Loïc Cosset; Els Verhoeyen
Journal:  Viruses       Date:  2020-09-11       Impact factor: 5.048
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.